House
File
2401
H-8179
Amend
House
File
2401
as
follows:
1
1.
Page
1,
before
line
1
by
inserting:
2
<
DIVISION
I
3
PHARMACY
BENEFITS
MANAGERS
>
4
2.
Page
1,
by
striking
lines
6
through
14
and
inserting
5
<
prescription
drugs
are
equivalent
to
the
payments
the
pharmacy
6
benefits
manager
makes
to
the
dispensing
pharmacy
or
dispensing
7
health
care
provider
for
the
prescription
drugs,
including
any
8
professional
dispensing
fee.
>
9
3.
Page
3,
by
striking
lines
11
and
12
and
inserting:
10
<
a.
If
a
pharmacy’s
appeal
is
found
to
be
substantiated,
the
11
pharmacy
benefits
manager
shall
do
all
of
the
>
12
4.
Page
3,
by
striking
lines
27
and
28
and
inserting:
13
<
b.
If
a
pharmacy’s
appeal
is
found
to
be
unsubstantiated,
14
the
pharmacy
benefits
manager
shall
do
all
of
the
>
15
5.
Page
4,
line
11,
after
<
rate.
>
by
inserting
<
The
16
adjustment
to
the
maximum
allowable
cost
or
the
reimbursement
17
rate
shall
be
applicable
to
all
of
the
following:
>
18
6.
Page
4,
after
line
11
by
inserting:
19
<
(a)
Each
pharmacy
that
is
under
common
ownership
with
the
20
pharmacy
that
submitted
the
appeal.
21
(b)
Each
pharmacy
in
the
state
that
demonstrates
the
22
inability
to
purchase
the
prescription
drug
for
less
than
the
23
established
maximum
allowable
cost
or
reimbursement
rate.
>
24
7.
Page
4,
line
12,
after
<
This
>
by
inserting
<
division
of
25
this
>
26
8.
Page
4,
after
line
14
by
inserting:
27
<
DIVISION
___
28
PHARMACY
SERVICES
ADMINISTRATIVE
ORGANIZATIONS
AND
WHOLESALE
29
DISTRIBUTION
——
REPORT
30
Sec.
___.
PHARMACY
SERVICES
ADMINISTRATIVE
ORGANIZATIONS
31
AND
WHOLESALE
DISTRIBUTION
OF
PRESCRIPTION
DRUGS
——
32
REPORT.
Before
January
1,
2025,
the
commissioner
or
the
33
commissioner’s
designee
shall
review
pharmacy
services
34
administrative
organizations
and
the
wholesale
distribution
of
35
-1-
HF
2401.3542
(2)
90
nls/ko
1/
2
#1.
#2.
#3.
#4.
#5.
#6.
#7.
#8.
prescription
drugs,
and
submit
a
report
to
the
general
assembly
1
containing
findings
and
recommendations
based
on
the
review.
2
The
report
shall
contain,
at
a
minimum,
all
of
the
following:
3
1.
A
description
and
analysis
of
the
prescription
drug
4
wholesale
distribution
supply
chain,
including
an
analysis
of
5
the
concentration
of
the
market
for
the
wholesale
distribution
6
of
prescription
drugs,
margins
in
the
wholesale
distribution
of
7
prescription
drugs,
and
the
availability
of
competition
in
the
8
wholesale
distribution
of
prescription
drugs.
9
2.
A
description
of
the
role
that
pharmacy
services
10
administrative
organizations
serve
in
the
prescription
drug
11
supply
chain.
12
3.
A
description
and
analysis
of
the
relationships
between
13
pharmacy
services
administrative
organizations,
prescription
14
drug
wholesalers,
and
retail
pharmacies,
including
standard
15
contracting
terms,
fees
charged
to
pharmacies,
and
contractual
16
restrictions
and
limitations
applicable
to
retail
pharmacies.
>
17
9.
By
renumbering
as
necessary.
18
______________________________
LUNDGREN
of
Dubuque
-2-
HF
2401.3542
(2)
90
nls/ko
2/
2
#9.